Increased miR-132 circulating levels have been associated with T2D and nephropathy and approaches to targeting it did impair blood glucose and improved insulin secretion (Bijkerk et al., 2015; Bijkerk et al., 2019; Florijn et al., 2019). This evidence concerns the gene INS and type 2 diabetes mellitus.